The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics-Reference-Cited by-同舟云学术

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Published:2018-07-06 Issue:1 Volume:10 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Bos Isabelle,Vos Stephanie,Vandenberghe Rik,Scheltens Philip,Engelborghs Sebastiaan,Frisoni Giovanni,Molinuevo José Luis,Wallin Anders,Lleó Alberto,Popp Julius,Martinez-Lage Pablo,Baird Alison,Dobson Richard,Legido-Quigley Cristina,Sleegers Kristel,Van Broeckhoven Christine,Bertram Lars,ten Kate Mara,Barkhof Frederik,Zetterberg Henrik,Lovestone Simon,Streffer Johannes,Visser Pieter Jelle

Funder

Innovative Medicine Initiative

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-018-0396-5.pdf

Reference38 articles.

1. Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207–16.

2. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367(9):795–804.

3. Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron. 2014;84(3):608–22.